Equine herpesvirus-1 myeloencephalopathy: A review of recent developments

Veterinary Journal

Volumn 180, Issue 3, 2009, Pages 279-289

  Pusterla, Nicola ^a   David Wilson, W ^a   Madigan, John E ^a   Ferraro, Gregory L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biosecurity; Diagnosis; Equine herpes myeloencephalopathy (EHM); Equine herpes virus (EHV) 1; Prevention; Treatment

Indexed keywords

ACICLOVIR; ALBUMIN; CALVENZA; CEFTIOFUR; COTRIMOXAZOLE; DEXAMETHASONE; DIMETHYL SULFOXIDE; DUVAXYN; FLUNIXIN MEGLUMINE; HERPES VACCINE; IMMUNOGLOBULIN G; INACTIVATED VACCINE; INNOVATOR; LIVE VACCINE; PNEUMABORT K 1B; PREDNISOLONE ACETATE; PRESTIGE; PRODIGY; RHINOMUNE; SULFONAMIDE; UNCLASSIFIED DRUG; VALACICLOVIR; VIRUS ANTIBODY;

CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC TEST; DRUG BIOAVAILABILITY; DRUG ELIMINATION; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EQUINE HERPES VIRUS; EXPERIMENTAL STUDY; HORSE DISEASE; INFECTION CONTROL; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROLOGY; SINGLE DRUG DOSE; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; DISEASE OUTBREAKS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSE DISEASES; HORSES; NERVOUS SYSTEM DISEASES;

EQUID HERPESVIRUS 1; EQUIDAE; EQUUS CABALLUS; HERPES; HUMAN HERPESVIRUS 1;

EID: 61849110275     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2008.08.004     Document Type: Review

References (71)

1. Adair J.C., Gold M., and Bond R.E. Acyclovir neurotoxicity: clinical experience and review of the literature. Southern Medical Journal 87 (1994) 1227-1231
2. Allen G.P. Development of a real-time polymerase chain reaction assay for rapid diagnosis of neuropathogenic strains of equine herpesvirus-1. Journal of Veterinary Diagnostic Investigation 19 (2007) 69-72
3. Allen G.P., and Breathnach C.C. Quantification by real-time PCR of the magnitude and duration of leukocyte-associated viremia in horses infected with neuropathogenic versus non-neuropathogenic strains of EHV-1. Equine Veterinary Journal 38 (2006) 252-257
4. Allen G.P., and Bryans J.T. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infection. Progress in Veterinary Microbiology and Immunology 2 (1986) 78-144
5. Ballagi-Pordany A., Klingeborn B., Flensburg J., and Belak S. Equine herpesvirus type 1: detection of viral DNA sequences in aborted fetuses with the polymerase chain reaction. Veterinary Microbiology 22 (1990) 373-381
6. Bentz B.G., Maxwell L.K., Erkert R.S., Royer C.M., Davis M.S., MacAllister C.G., and Clarke C.R. Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. Journal of Veterinary Internal Medicine 20 (2006) 589-594
7. Bentz, B.G., Maxwell, L.K., Bourne, D.W.A., Erkert, R.S., 2007. Pharmacokinetics of valacyclovir in the adult horse. In: Proceedings of the 25th Annual Meeting of the American College of Veterinary Internal Medicine, Seattle, USA, p. 601.
8. Blythe L.L., Mattson D.E., Lassen E.D., and Craig A.M. Antibodies against equine herpesvirus 1 in the cerebrospinal fluid in the horse. Canadian Veterinary Journal 26 (1985) 218-220
9. Borchers K., and Slater J. A nested PCR for the detection and differentiation of EHV-1 and EHV-4. Journal of Virology Methods 45 (1993) 331-336
10. Burrows R., Goodridge D., and Denyer M.S. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus. Veterinary Record 114 (1984) 369-374
11. Crabb B.S., and Studdert M.J. Epitopes of glycoprotein G of equine herpesviruses 4 and 1 located near the C termini elicit type-specific antibody responses in the natural host. Journal of Virology 67 (1993) 6332-6338
12. Crabb B.S., MacPherson C.M., Reubel G.H., Browning G.F., Studdert M.J., and Drummer H.E. A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1. Archives of Virology 140 (1995) 245-258
13. Diallo I.S., Hewitson G., Wright L., Rodwell B.J., and Corney B.G. Detection of equine herpesvirus type 1 using a real-time polymerase chain reaction. Journal of Virology Methods 131 (2006) 92-98
14. Donaldson M.T., and Sweeney C.R. Herpesvirus myeloencephalopathy in horses: 11 cases (1982-1996). Journal of the American Veterinary Medical Association 213 (1998) 671-675
15. Drummer H.E., Reynolds A., Studdert M.J., MacPherson C.M., and Crabb B.S. Application of an equine herpesvirus 1 (EHV1) type-specific ELISA to the management of an outbreak of EHV1 abortion. Veterinary Record 136 (1995) 579-581
16. Edington N., Bridges C.G., and Patel J.R. Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Archive of Virology 90 (1986) 111-124
17. Elia G., Decaro N., Martella V., Campolo M., Desario C., Lorusso E., Cirone F., and Buonavoglia C. Detection of equine herpesvirus type 1 by real time PCR. Journal of Virology Methods 133 (2006) 70-75
18. Foote C.E., Love D.N., Gilkerson J.R., Rota J., Trevor-Jones P., Ruitenberg K.M., Wellington J.E., and Whalley J.M. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Veterinary Immunology and Immunopathology 105 (2005) 47-57
19. Friday P.A., Scarratt W.K., Elvinger F., Timoney P.J., and Bonda A. Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses. Journal of Veterinary Internal Medicine 14 (2000) 197-201
20. Garré B., van der Meulen K., Nugent J., Neyts J., Croubels S., De Backer P., and Nauwynck H. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. Veterinary Microbiology 122 (2007) 43-51
21. Garré B., Shebany K., Gryspeerdt A., Baert K., van der Meulen K., Nauwynck H., Deprez P., De Backer P., and Croubels S. Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir I healthy adult horses. Antimicrobial Agents and Chemotherapy 51 (2007) 4308-4314
22. Goodman L.B., Wagner B., Flaminio M.J., Sussman K.H., Metzger S.M., Holland R., and Osterrieder N. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 24 (2006) 3636-3645
23. Heldens J.G., Hannant D., Cullinane A.A., Prendergast M.J., Mumford J.A., Nelly M., Kydd J.H., Weststrate M.W., and van den Hoven R. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 19 (2001) 4307-4317
24. Henninger R.W., Reed S.M., Saville W.J., Allen G.A., Hass G.F., Kohn C.W., and Sofaly C. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. Journal of Veterinary Internal Medicine 21 (2007) 157-165
25. Holmes M.A., Townsend H.G., Kohler A.K., Hussey S., Breathnach C., Barnett C., Holland R., and Lunn D.P. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Veterinary Immunology and Immunopathology 111 (2006) 67-80
26. Hussey S.B., Clark R., Lunn K.F., Breathnach C., Soboll G., Whalley J.M., and Lunn D.P. Detection and quantification of equine herpesvirus-1 viremia and nasal shedding by real-time polymerase chain reaction. Journal of Veterinary Diagnostic Investigation 18 (2006) 335-342
27. Jackson T.A., and Kendrick J.W. Paralysis of horses associated with equine herpesvirus 1 infection. Journal of the American Veterinary Medical Association 158 (1971) 1351-1357
28. Jackson T.A., Osburn B.I., Cordy D.R., and Kendrick J.W. Equine herpesvirus 1 infection of horses: studies on the experimentally induced neurologic disease. American Journal of Veterinary Research 38 (1977) 709-719
29. Keane D.P., Little P.B., Wilkie B.N., Artsob H., and Thorsen J. Agents of equine viral encephalomyelitis: correlation of serum and cerebrospinal fluid antibodies. Canadian Journal of Veterinary Research 52 (1988) 229-235
30. Kirisawa R., Endo A., Iwai H., and Kawakami Y. Detection and identification of equine herpesvirus-1 and -4 by polymerase chain reaction. Veterinary Microbiology 36 (1993) 57-67
31. Klingeborn B., Dinter Z., and Hughes R.A. Antibody to neuritogenic myelin protein P2 in equine paresis due to equine herpesvirus 1. Zentralblatt für Veterinärmedizin B 30 (1983) 137-140
32. Kohn C.W., and Fenner W.R. Equine herpes myeloencephalopathy. Veterinary Clinics of North America Equine Practice 3 (1987) 405-419
33. Kohn C.W., Reed S.M., Sofaly C.D., Henninger R.W., Saville W.J., Allen G.P., and Premanadan C. Transmission of EHV-1 in horses with EHV-1 myeloencephalopathy: implications for biosecurity and review. Clinical Techniques in Equine Practice 5 (2006) 60-66
34. Lawrence G.L., Gilkerson J., Love D.N., Sabine M., and Whalley J.M. Rapid, single-step differentiation of equid herpesviruses 1 and 4 from clinical material using the polymerase chain reaction and virus-specific primers. Journal of Virology Methods 47 (1994) 59-72
35. Leutenegger C.M., Madigan J.E., Mapes S., Thao M., Estrada M., and Pusterla N. Detection of EHV-1 neuropathogenic strains using real-time PCR in the neural tissue of horses with myeloencephalopathy. Veterinary Record 162 (2008) 688-689
36. McCartan C.G., Russell M.M., Wood J.L., and Mumford J.A. Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm. Veterinary Record 136 (1995) 7-12
37. Minke J.M., Fischer L., Baudu P., Guigal P.M., Sindle T., Mumford J.A., and Audonnet J.C. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Veterinary Immunology and Immunopathology 111 (2006) 47-57
38. Moore, B.O., Koonse, H.J., 1978. Inactive equine herpesvirus I vaccine - Pneumaboar-K. In: Proceedings of the 24th Annual Meeting of the American Association of Equine Practitioners, St. Louis, USA, pp. 75-79.
39. Mumford J.A. The development of diagnostic techniques for equine viral diseases. Veterinary Annals 24 (1984) 182-189
40. Mumford J.A. Equine herpesvirus 1 (EHV 1) latency: more questions than answers. Equine Veterinary Journal 17 (1985) 340-342
41. Murray M.J., del Piero F., Jeffrey S.C., Davis M.S., Furr M.O., Dubovi E.J., and Mayo J.A. Neonatal equine herpesvirus type 1 infection on a thoroughbred breeding farm. Journal of Veterinary Internal Medicine 12 (1998) 36-41
42. Nugent J., Birch-Machin I., Smith K.C., Mumford J.A., Swann Z., Newton J.R., Bowden R.J., Allen G.P., and Davis-Poynter N. Analysis of equine herpesvirus type 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus non-neuropathogenic disease outbreaks. Journal of Virology 80 (2006) 4047-4060
43. Ostlund E.N. The equine herpesviruses. Veterinary Clinics of North America Equine Practice 9 (1993) 283-294
44. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C., Minke J.M., Davis-Poynter N., Hannant D., and Kydd J.H. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24 (2006) 1490-1500
45. Paradis M.R. Equine herpesvirus. In: Smith B.A. (Ed). Large Animal Internal Medicine. second ed. (1996), Mosby, St. Louis, USA 587-588
46. Patel J.R., and Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) - epidemiology, disease and immunoprophylaxis: a brief review. The Veterinary Journal 170 (2005) 14-23
47. Patel J.R., Földi J., Bateman H., Williams J., Didlick S., and Stark R. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Veterinary Microbiology 92 (2003) 1-17
48. Patel J.R., Bateman H., Williams J., and Didlick S. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Veterinary Microbiology 91 (2003) 23-39
49. Patel J.R., Didlick S., and Bateman H. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection. Equine Veterinary Journal 36 (2004) 447-451
50. Peet R.L., Coackley W., Smith V.W., and Main C. Equine abortion associated with herpesvirus. Australian Veterinary Journal 44 (1978) 151
51. Perkins, G.A., Goodman, L.B., Tsujimura, K., Van de Walle, G.R., Kim, S.G., Dubovi, E., Osterrieder, N., 2008. Investigation of neurologic equine herpes virus 1 epidemiology from 1984 to 2007. In: Proceedings of the 26th Annual Meeting of the American College of Veterinary Internal Medicine, San Antonio, USA. p. 819.
52. Pusterla N., Leutenegger C.M., Wilson W.D., Watson J.L., Ferraro G.L., and Madigan J.E. Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative real-time TaqMan PCR. Journal of Veterinary Diagnostic Investigation 17 (2005) 578-581
53. Pusterla N., Wilson W.D., Conrad P.A., Barr B.C., Ferraro G.L., Daft B.M., and Leutenegger C.M. Cytokine gene signatures in neural tissue of horses with equine protozoal myeloencephalitis or equine herpes type 1 myeloencephalopathy. Veterinary Record 159 (2006) 341-346
54. Pusterla N., Mapes S., and Wilson W.D. Use of viral loads in blood and nasopharyngeal secretions for the diagnosis of EHV-1 infection in field cases. Veterinary Record 31 (2008) 728-729
55. Pusterla N., Wilson W.D., Mapes S., Finno C., Isbell D., Arthur R.M., and Ferraro G.L. Characterization of viral loads, strain and state of equine herpesvirus-1 using real-time PCR in horses following natural exposure at a racetrack in California. Veterinary Journal (2008) 10.1016/j.tvjl.2007.09.018 Epub ahead of print
56. Reed S.M., and Toribio R.T. Equine herpesvirus 1 and 4. Veterinary Clinics of North America Equine Practice 20 (2004) 631-642
57. Rollinson E.A., and White G. Relative sensitivities of acyclovir in vitro and in vivo. Journal of Antimicrobial Chemotherapy 12 (1983) 19-27
58. Schmidt P., Meyer H., Hübert P., Hafner A., Andiel E., Grabner A., and Dahme E. In situ hybridization for demonstration of equine herpesvirus type 1 DNA in paraffin wax-embedded tissues in its use in horses with disseminated necrotizing myeloencephalitis. Journal of Comparative Pathology 110 (1994) 215-225
59. Sharma P.C., Cullinane A.A., Onions D.E., and Nicolson L. Diagnosis of equid herpesviruses-1 and -4 by polymerase chain reaction. Equine Veterinary Journal 24 (1992) 20-25
60. Slater J. Equine herpesviruses. In: Sellon D., and Long M. (Eds). Equine Infectious Diseases (2007), Saunders Elsevier, St. Louis, USA 134-153
61. Smith K.O., Galloway K.S., Hodges S.L., Ogilvie K.K., Radatus B.K., Kalter S.S., and Heberling R.L. Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl] guanine. American Journal of Veterinary Research 44 (1983) 1032-1035
62. Soboll G., Hussey S.B., Whalley J.M., Allen G.P., Koen M.T., Santucci N., Fraser D.G., Macklin M.D., Swain W.F., and Lunn D.P. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. Veterinary Immunology and Immunopathology 111 (2006) 81-95
63. Van Maanen C. Equine herpesvirus 1 and 4 infections: an update. Veterinary Quarterly 24 (2002) 58-78
64. Van Maanen C., Sloet van Oldruitenborgh-Oosterbaan M.M., Damen E.A., and Derksen A.G. Neurological disease associated with EHV-1-infection in a riding school: clinical and virological characteristics. Equine Veterinary Journal 33 (2001) 191-196
65. Wagner W.N., Bogdan J., Haines D., Townsend H.G., and Misra V. Detection of equine herpesvirus and differentiation of equine herpesvirus type 1 from type 4 by the polymerase chain reaction. Canadian Journal of Microbiology 38 (1992) 1193-1196
66. Whitwell K.E., Gower S.M., and Smith K.C. An immunoperoxidase method applied to the diagnosis of equine herpesvirus abortion, using conventional and rapid microwave techniques. Equine Veterinary Journal 24 (1992) 10-12
67. Wilkins, P.A., 2004. Acyclovir in the treatment of EHV-1 myeloencephalopathy. In: Proceedings of the 22nd Annual Meeting of the American College of Veterinary Internal Medicine, Minneapolis, USA, pp. 170-172.
68. Wilkins P.A., Papich M., and Sweeney R. Pharmacokinetics of acyclovir in adult horses. Journal of Veterinary Emergency and Critical Care 15 (2005) 174-178
69. Wilson, J.H., 1991. Neurological syndrome of rhinopneumonitis. In: Proceedings of the Ninth Annual Meeting of the American College of Veterinary Internal Medicine, San Diego, USA, pp. 419-421.
70. Wilson W.D. Equine herpesvirus 1 myeloencephalopathy. Veterinary Clinics of North America Equine Practice 13 (1997) 53-72
71. Wilson W.D., and Pusterla N. Equine herpesvirus 1 myeloencephalopathy. In: Reed S.M., Bayly W.M., and Sellon D.C. (Eds). Equine Internal Medicine (2004), Saunders Elsevier, St. Louis, USA 617-628